Fundz

Nex Immune, Inc. reported raising $7.77 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEFeb 22, 2019$7.8M of $10M raised

Amount Raised

$7.77 Million

$7.77 Million sold, per SEC Form D (first sale Feb 22, 2019)

Round Type

Venture

GaithersburgBiotechnology

Quick answer

NexImmune, Inc. raised $7.77 Million in a funding round, dated February 22, 2019. NexImmune, Inc. is based in Gaithersburg, Maryland, United States.

How much did NexImmune, Inc. raise?
NexImmune, Inc. raised $7.77 Million in a funding round on February 22, 2019.
What does NexImmune, Inc. do?
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
Where is NexImmune, Inc. based and how big is it?
NexImmune, Inc. is based in Gaithersburg, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as NexImmune, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at NexImmune, Inc., and when

A new round usually means NexImmune, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NexImmune, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NexImmune, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NexImmune, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NexImmune, Inc.

Location

9119 Gaither Road

Gaithersburg, Maryland, United States

About

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NexImmune, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NexImmune, Inc.'s next move

See what Strategic adds

NexImmune, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.